CAMP4 Therapeutics Corp
NASDAQ:CAMP

Watchlist Manager
CAMP4 Therapeutics Corp Logo
CAMP4 Therapeutics Corp
NASDAQ:CAMP
Watchlist
Price: 7.13 USD 1.71% Market Closed
Market Cap: 334.3m USD

Net Margin
CAMP4 Therapeutics Corp

-1 397.9%
Current
-3 811%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 397.9%
=
Net Income
-53.1m
/
Revenue
3.8m

Net Margin Across Competitors

No Stocks Found

CAMP4 Therapeutics Corp
Glance View

Market Cap
334.3m USD
Industry
Biotechnology

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company is headquartered in Cambridge, Massachusetts and currently employs 53 full-time employees. The company went IPO on 2024-10-11. The company is leveraging its RAP Platform to advance a pipeline of programs initially focused on metabolic and central nervous system (CNS) disorders with validated disease biology and potential market opportunities due to the significant unmet need of affected patients. Its lead product candidate, CMP-CPS-001, has the potential to be the first disease-modifying therapy for the treatment of urea cycle disorders. CMP-CPS-001 is designed to improve urea cycle activity by amplifying expression of CPS1, a key enzyme that catalyzes the first step of the urea cycle, by binding to a CPS1-specific regRNA. Its CNS development program, CMP-SYNGAP, is focused on addressing the underlying cause of SYNGAP1-related disorders.

CAMP Intrinsic Value
0.25 USD
Overvaluation 97%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 397.9%
=
Net Income
-53.1m
/
Revenue
3.8m
What is the Net Margin of CAMP4 Therapeutics Corp?

Based on CAMP4 Therapeutics Corp's most recent financial statements, the company has Net Margin of -1 397.9%.

Back to Top